As expected, anti-PD-1 augmented radiation-induced tumor growth inhibition (Figure 5B–D), and the addition of entinostat to IR plus anti-PD-1 had a better tumor control effect (Figure 5B–D). The gene discussed is PDCD1; the disease is neoplasm.